NCT06076200View on ClinicalTrials.gov

Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2023

Primary Completion Date

July 1, 2026

Study Completion Date

December 31, 2026

Conditions
Early-Onset Neonatal Sepsis
Interventions
DRUG

Piperacillin Sodium and Tazobactam Sodium for Injection

Piperacillin/Tazobactam, specification: 4g; 0.5g. Anti-infective therapy with piperacillin/tazobactam, specific regimen based on clinical practice, without intervention.

Trial Locations (1)

Unknown

RECRUITING

Shandong Provincial Hospital, Jinan

All Listed Sponsors
collaborator

Shandong Provincial Hospital

OTHER_GOV

lead

Shandong University

OTHER